"c-Mer Tyrosine Kinase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A receptor tyrosine kinase that transduces signals from EXTRACELLULAR MATRIX to the CYTOPLASM by binding ligands such as GALECTIN 3. It regulates many physiologic processes that include cell survival, migration, differentiation, and PHAGOCYTOSIS of apoptotic cells and ROD PHOTORECEPTORS in the RETINAL PIGMENT EPITHELIUM. Mutations in the MERTK gene are associated with type 38 RETINITIS PIGMENTOSA; it also plays a critical role as an inhibitor of TOLL-LIKE RECEPTORS signaling.
Descriptor ID |
D000076202
|
MeSH Number(s) |
D08.811.913.696.620.682.725.400.003 D12.776.543.750.630.003 D12.776.624.664.700.037
|
Concept/Terms |
c-Mer Tyrosine Kinase- c-Mer Tyrosine Kinase
- Kinase, c-Mer Tyrosine
- Tyrosine Kinase, c-Mer
- c Mer Tyrosine Kinase
- c-Mer Proto-Oncogene Tyrosine Kinase
- c Mer Proto Oncogene Tyrosine Kinase
- MERTK
|
Below are MeSH descriptors whose meaning is more general than "c-Mer Tyrosine Kinase".
Below are MeSH descriptors whose meaning is more specific than "c-Mer Tyrosine Kinase".
This graph shows the total number of publications written about "c-Mer Tyrosine Kinase" by people in this website by year, and whether "c-Mer Tyrosine Kinase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2023 | 0 | 1 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "c-Mer Tyrosine Kinase" by people in Profiles.
-
MerTK Drives Proliferation and Metastatic Potential in Triple-Negative Breast Cancer. Int J Mol Sci. 2024 May 08; 25(10).
-
Dual Axl/MerTK inhibitor INCB081776 creates a proinflammatory tumor immune microenvironment and enhances anti-PDL1 efficacy in head and neck cancer. Head Neck. 2023 05; 45(5):1255-1271.